PERCEPTIVE ADVISORS
Perceptive Advisors, LLC is a privately owned hedge fund sponsor. The firm invests in the public equity markets across the globe. It employs a long/short equity strategy as a hedging technique while making its investments. The firm typically invests in biotechnology and life sciences sectors to make its investments. Perceptive Advisors is based in New York, New York.
PERCEPTIVE ADVISORS
Social Links:
Industry:
Finance Financial Services Venture Capital
Founded:
1999-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins
Similar Organizations
Carlyle-Blue Wave Partners Management
Carlyle-Blue Wave Partners Management is privately owned hedge fund sponsor. The firm invests in the public equity, fixed income.
Pamplona Capital Management
Pamplona Capital Management LLP is a privately owned hedge fund sponsor. The firm manages hedge fund of funds for its clients.
Current Advisors List
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-09-07 | SpringWorks Therapeutics | Perceptive Advisors investment in Post-IPO Equity - SpringWorks Therapeutics | 225 M USD |
2022-09-01 | InSightec | Perceptive Advisors investment in Debt Financing - InSightec | 100 M USD |
2022-08-03 | MeiraGTx | Perceptive Advisors investment in Post-IPO Debt - MeiraGTx | 75 M USD |
2022-06-28 | Cerebral Therapeutics | Perceptive Advisors investment in Series C - Cerebral Therapeutics | 40 M USD |
2022-04-12 | Surf Bio | Perceptive Advisors investment in Seed Round - Surf Bio | 16 M USD |
2022-04-08 | Lyra Therapeutics | Perceptive Advisors investment in Post-IPO Equity - Lyra Therapeutics | 100.5 M USD |
2022-03-30 | Neuron23 | Perceptive Advisors investment in Series C - Neuron23 | 100 M USD |
2022-03-30 | VivoSense | Perceptive Advisors investment in Series A - VivoSense | 25 M USD |
2022-03-08 | DNAnexus | Perceptive Advisors investment in Series H - DNAnexus | 200 M USD |
2022-02-23 | Omada Health | Perceptive Advisors investment in Series E - Omada Health | 192 M USD |
More informations about "Perceptive Advisors"
Perceptive Advisors - Wikipedia
Perceptive Advisors was founded in July 1999 by Joseph Edelman. Edelman was previously a senior analyst at Aries Fund, a Paramount Capital Asset Management biotechnology hedge fund as well as a senior bBiotechnology analyst at Prudential Securities. His father was Isidore Edelman, a physician and researcher who became chair of the biochemistry and molecular biophysics department at Columbia University. See details»
About โ Perceptive Advisors
Founded in 1999, Perceptive Advisors focuses on supporting progress in the life sciences industry by identifying opportunities and directing financial resources toward the most promising technologies in modern healthcare. Today, the firm โฆSee details»
Team - Perceptive Advisors
The Perceptive team brings vast industry knowledge and a dynamic approach. We are passionately committed to identifying innovation that can drive critical change. Through trials and analysis, we solidify our theories into competitive โฆSee details»
Joseph Edelman - CEO - Perceptive Advisors | LinkedIn
CEO at Perceptive Advisors · Joseph Edelman is the Chief Executive Officer and founder of Perceptive Advisors LLC, a New York City-based hedge fund that specializes in biotechnology stocks, which ...See details»
A rising star at $8.8 billion Perceptive Advisors breaks โฆ
May 12, 2021 Perceptive Advisors' Ellen Hukkelhoven broke down why the $8.8 billion manager is a fan of BridgeBio. ... and the company can be "a nimble organization of truthseekers" instead of hypemen for a ...See details»
Perceptive Advisors closes $515M fund to fuel more early-stage โฆ
May 12, 2021 Perceptive Advisors has $515 million for its second fund investing in biotech startups. Portfolio Manager Chris Garabedian says Perceptive Xontogeny Ventures Fund II is โฆSee details»
Perceptive Advisors - F6S
Perceptive Advisors focuses on supporting progress in the life sciences industry by identifying opportunities and directing financial resources toward the most promising technologies in โฆSee details»
Perceptive Advisors Enters Into Definitive Merger โฆ
Colorado โ June 17, 2024 โ Cooley advised Perceptive Advisors, a top healthcare investment firm, and its affiliates, including Perceptive Discovery Fund, on its definitive merger agreement with Vapotherm, a publicly traded โฆSee details»
Perceptive Advisors investment portfolio - PitchBook
Perceptive Advisors General Information Company Description. Founded in 1999, Perceptive Advisors is a hedge fund manager based in New York, New York. The firm pursues โฆSee details»
Joseph Edelman โ Perceptive Advisors
Joseph Edelman is the Chief Executive Officer and founder of Perceptive Advisors LLC, a New York City-based hedge fund that specializes in biotechnology stocks, which he founded in โฆSee details»
Perceptive Advisors unveils $515M fund, its 2nd for early-stage ...
May 12, 2021 After 20 years of backing clinical-stage biotechs, Perceptive Advisors took a leap in 2019, teaming up with Chris Garabedianโs Xontogeny to invest in earlier-stage companies. โฆSee details»
Joseph Edelman - CEO & Founder @ Perceptive Advisors
Joseph Edelman founded Perceptive Advisors, LLC in 1999, a hedge fund focused on supporting the progress of the life sciences industry. Under Joeโs leadership, Perceptive has grown into โฆSee details»
Joseph Edelman - Forbes
4 days ago Edelman founded Perceptive Advisors in 1999 and focuses on investing in biotechnology stocks. Edelman's main Perceptive Life Sciences hedge fund lost money only โฆSee details»
SEC Charges Perceptive Advisors for Failing to Disclose SPAC โฆ
Sep 6, 2022 The Perceptive personnel were entitled to a portion of the compensation the SPAC sponsors received upon completion of the SPACsโ business combinations. The SECโs order โฆSee details»
Investments - Perceptive Advisors
Perceptive invests in the technologies, leaders, and advancements that our team identifies as transformative within their fields. ... The portfolio companies shown represent a portion of โฆSee details»
BTL Announces First Close of $56 Million Growth Financing
NORTHBROOK, Ill., Aug. 19, 2021 /PRNewswire/ โ Bridge to Life, Ltd. (โBridge to Lifeโ or the โCompanyโ), a leading global supplier of organ preservation solutions and organ perfusion โฆSee details»
The 41% Man - Institutional Investor
Aug 13, 2018 Edelman, 63, founded his biotechnology hedge fund firm, Perceptive Advisors, in 1999. Since then the firm, which started with $6 million in assets, has swelled to $4.1 billion on โฆSee details»
Life Sciences - Perceptive Advisors
Perceptive Advisors has made global investments in public and private companies developing biotechnology products, drugs, medical devices and diagnostics for over 24 years. We invest โฆSee details»
Perceptive Advisors Posts Best Results Since 2000, Gaining 54%
Jan 15, 2020 Joseph Edelmanโs Perceptive Advisors delivered its best year since the life science fundโs first full operating year in 2000. The Perceptive Life Sciences Fund surged 53.7 โฆSee details»